Richard Barohn
Former Executive Vice Chancellor for Health Affairs · University of Missouri System
Credentials: · · · · · · ·
History
PresentSchool of Medicine · University of Missouri System
- Present
University of Missouri School of Medicine · University of California
- 1990–1991
Clinical Neurophysiology
- 1983–1986
Research
Review · Neurology · 2000 · 1,208 citations
Annals of the Rheumatic Diseases · 2017 · 1,129 citations
Cell · 2001 · 730 citations
104 papers
- AA
59 papers · 6 as a fellow
54 papers · 5 as a fellow
49 papers · 10 as a resident
47 papers
- JK
43 papers
- JK
36 papers
31 papers
Grants
- 2017–2022
Frontiers Clinical and Translational Science Institute at the University of Kansas
National Center for Advancing Translational Sciences · UL1
Contact PI · $8.1M · University of Kansas Medical Center
- 2013–2021
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Food and Drug Administration · R01
Contact PI · $984.1K · University of Missouri-Columbia
- 2011–2020
Heartland Unit for Neuroscience Trials
National Institute of Neurological Disorders and Stroke · U10
Contact PI · $2.1M · University of Kansas Medical Center
- 2013–2019
A Phase II Trial of Rituximab In Myasthenia Gravis
National Institute of Neurological Disorders and Stroke · U01
PI · $4.5M · Yale University
Clinical trials
- 2018–2021
Therapy in Amyotrophic Lateral Sclerosis (TAME)
Principal investigator · Completed · Phase 2
University of Kansas Medical Center
- 2014–2017
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations
Principal investigator · Completed · Phase 4
University of Kansas Medical Center
- 2013–2016
Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Principal investigator · Completed · Phase 2
Richard Barohn, MD
- 2009–2014
Efficacy of Methotrexate in Myasthenia Gravis
Principal investigator · Completed · Phase 2
University of Kansas Medical Center